ReproUnion
Reproductive Medicine Across BordersWhen asking young people, most envision a life with children, but reproductive challenges affect up to 25% of couples in Scandinavia. Every 8th woman never becomes a mother, and every 5th man never becomes a father.
With a new research and innovation paradigm within reproductive medicine in the Øresund Region, ReproUnion wants to meet current and future demands of preventing, managing, and treating infertility. Infertility is recognized as a disease by the WHO, but despite revolutionary developments in the techniques for assisted reproduction, the success rate is still below 30%.
ReproUnion drives fertility collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve fertility treatment. We also work on preventive initiatives to ensure that the society and young people are equipped with the right information to make informed choices about family planning.
News
Find out what’s going on & stay up to date
MVA Summit features RUBIC: The golden egg in women’s and men’s fertility research
At the Medicon Valley Alliance Summit ReproUnion presented how research using the cross-border biobank can bring us closer to understand the reasons for infertility, while underlining the importance of the couple-centric approach, which makes RUBIC a true pioneer in this field.
Welcome back Mette Bach Dyremose
We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's...
RUBIC Seminar – The Team Makes the Dream Work
On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient...